Biomedical and public health research in the United States now finds itself in an existential moment. The government’s proposed changes, if allowed to take place, will absolutely decimate not just the nation’s but the world’s ability to study disease, therapeutics, and health outcomes.

Research out of Brown University is making its way to the national spotlight. It concerns the overdose prevention center in Providence.

Fatalities from drugs including fentanyl are down from recent peaks.

The question of whether harm reduction efforts are failing remains complex. To delve deeper into this evolving issue, Newsweek has reached out to medical experts for further insights.